January, 2017

BOS beat placebo for eosinophilic esophagitis

Budesonide oral suspension (BOS) was safe and significantly outperformed placebo on validated measures of ...

Sofosbuvir with velpatasvir beat other HCV GT3 regimens

Regimens containing sofosbuvir and velpatasvir were most effective for treating both cirrhotic and noncirrhotic ...

Syndax Appoints Lisa M. Coussens, Ph.D., to Scientific Advisory Board

WALTHAM, Mass., Jan. 31, 2017 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. ("Syndax," the “Company” ...

Syndax Appoints Lisa M. Coussens, Ph.D., to Scientific Advisory Board

WALTHAM, Mass., Jan. 31, 2017 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. ("Syndax," the “Company” ...